Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus

Purpose To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. Design Prospective randomized controlled clinical trial. Partici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2017-06, Vol.124 (6), p.804-812
Hauptverfasser: Lombardo, Marco, MD, PhD, Giannini, Daniela, MEng, Lombardo, Giuseppe, MEng, PhD, Serrao, Sebastiano, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 812
container_issue 6
container_start_page 804
container_title Ophthalmology (Rochester, Minn.)
container_volume 124
creator Lombardo, Marco, MD, PhD
Giannini, Daniela, MEng
Lombardo, Giuseppe, MEng, PhD
Serrao, Sebastiano, MD, PhD
description Purpose To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. Design Prospective randomized controlled clinical trial. Participants Thirty-four eyes of 25 participants with progressive keratoconus were randomized into T-ionto CL (22 eyes) or standard CL (12 eyes). Methods T-ionto CL was performed using an iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by irradiating the cornea with a 10 mW/cm2 ultraviolet A device for 9 minutes. Standard CL was performed according to the Dresden protocol. Main Outcome Measures The primary outcome measure was stabilization of keratoconus after 12 months through analysis of maximum simulated keratometry readings (Kmax , diopters). Other outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resolution [logMAR]), manifest spherical equivalent refraction (D), central corneal thickness (CCT, micrometers) and endothelial cell density (ECD). Follow-up examinations were arranged at 3 and 7 days and 1, 3, 6, and 12 months. Results Twelve months after T-ionto CL and standard CL, Kmax on average flattened by −0.52±1.30 D ( P  = 0.06) and −0.82±1.20 D ( P  = 0.04), respectively. The mean change in CDVA was −0.10±0.12 logMAR ( P  = 0.003) and −0.03±0.06 logMAR ( P  = 0.10) after T-ionto CL and standard CL, respectively. The manifest spherical equivalent refraction changed on average by +0.71±1.44 D ( P  = 0.03) and +0.21±0.76 D ( P  = 0.38), respectively. The CCT and ECD measures did not change significantly in any group at 12 months. Significant differences in the outcome measures between treatments were found in the first week postoperatively. No complications occurred in the T-ionto CL group; 1 eye (8%) had sterile corneal infiltrates, which did not affect the final visual acuity, in the standard CL group. Conclusions Significant visual and refractive improvements were found 12 months after T-ionto CL, though the average improvement in corneal topography readings was slightly lower than the Dresden protocol in the same period.
doi_str_mv 10.1016/j.ophtha.2017.01.040
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1876491613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016164201632259X</els_id><sourcerecordid>1876491613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-9ae7c5bf9aea0d0f020476d18edd119d271a275abffc5f20ab9b82eae442e1613</originalsourceid><addsrcrecordid>eNqFUstu1TAQtRCIXgp_gFCWbBJsx4mTDRK6vCoqgaCV2FmOPen1rWMHOykq38EHY5PCgg0bz-vMjGfOIPSU4Ipg0r44Vn4-LAdZUUx4hUmFGb6HdqRhfck4qe-jXYKRsmUUn6BHMR4xxm1bs4fohHa0qynvd-jnZ-m0n8wP0MXeuyV4a5N6EYy0yTHNMhh3lWzpIsxmOYDdIsFBlsHHWFrjrjPqMub3LJVJX_MBoonF95RTpLTidbI1uOJT8ItX3hbmt36V3NHcQPEBgswBt8bH6MEobYQnd_IUXb59c7F_X55_fHe2f3VeKkb4UvYSuGqGMUmJNR4xxYy3mnSgNSG9ppxIyhs5jKNqRorl0A8dBQmMUUirqU_R863uHPy3FeIiJhMVWCsd-DUK0vGW9RmZoGyDqjxxgFHMwUwy3AqCReZDHMXGh8h8CExE4iOlPbvrsA4T6L9JfwhIgJcbANKcNwaCiMqAU6BNALUI7c3_OvxbQCU6jJL2Gm4hHv0aXNqhICJSgcWXfBP5JEhbU9r0X-tfHPC3aQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1876491613</pqid></control><display><type>article</type><title>Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lombardo, Marco, MD, PhD ; Giannini, Daniela, MEng ; Lombardo, Giuseppe, MEng, PhD ; Serrao, Sebastiano, MD, PhD</creator><creatorcontrib>Lombardo, Marco, MD, PhD ; Giannini, Daniela, MEng ; Lombardo, Giuseppe, MEng, PhD ; Serrao, Sebastiano, MD, PhD</creatorcontrib><description>Purpose To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. Design Prospective randomized controlled clinical trial. Participants Thirty-four eyes of 25 participants with progressive keratoconus were randomized into T-ionto CL (22 eyes) or standard CL (12 eyes). Methods T-ionto CL was performed using an iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by irradiating the cornea with a 10 mW/cm2 ultraviolet A device for 9 minutes. Standard CL was performed according to the Dresden protocol. Main Outcome Measures The primary outcome measure was stabilization of keratoconus after 12 months through analysis of maximum simulated keratometry readings (Kmax , diopters). Other outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resolution [logMAR]), manifest spherical equivalent refraction (D), central corneal thickness (CCT, micrometers) and endothelial cell density (ECD). Follow-up examinations were arranged at 3 and 7 days and 1, 3, 6, and 12 months. Results Twelve months after T-ionto CL and standard CL, Kmax on average flattened by −0.52±1.30 D ( P  = 0.06) and −0.82±1.20 D ( P  = 0.04), respectively. The mean change in CDVA was −0.10±0.12 logMAR ( P  = 0.003) and −0.03±0.06 logMAR ( P  = 0.10) after T-ionto CL and standard CL, respectively. The manifest spherical equivalent refraction changed on average by +0.71±1.44 D ( P  = 0.03) and +0.21±0.76 D ( P  = 0.38), respectively. The CCT and ECD measures did not change significantly in any group at 12 months. Significant differences in the outcome measures between treatments were found in the first week postoperatively. No complications occurred in the T-ionto CL group; 1 eye (8%) had sterile corneal infiltrates, which did not affect the final visual acuity, in the standard CL group. Conclusions Significant visual and refractive improvements were found 12 months after T-ionto CL, though the average improvement in corneal topography readings was slightly lower than the Dresden protocol in the same period.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2017.01.040</identifier><identifier>PMID: 28283279</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Cell Count ; Collagen - metabolism ; Corneal Stroma - metabolism ; Corneal Topography ; Cross-Linking Reagents ; Endothelium, Corneal - pathology ; Female ; Humans ; Iontophoresis - methods ; Keratoconus - drug therapy ; Keratoconus - metabolism ; Keratoconus - physiopathology ; Male ; Ophthalmology ; Photochemotherapy - methods ; Photosensitizing Agents - therapeutic use ; Prospective Studies ; Refraction, Ocular - physiology ; Riboflavin - therapeutic use ; Ultraviolet Rays ; Visual Acuity - physiology ; Young Adult</subject><ispartof>Ophthalmology (Rochester, Minn.), 2017-06, Vol.124 (6), p.804-812</ispartof><rights>American Academy of Ophthalmology</rights><rights>2017 American Academy of Ophthalmology</rights><rights>Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-9ae7c5bf9aea0d0f020476d18edd119d271a275abffc5f20ab9b82eae442e1613</citedby><cites>FETCH-LOGICAL-c417t-9ae7c5bf9aea0d0f020476d18edd119d271a275abffc5f20ab9b82eae442e1613</cites><orcidid>0000-0002-4141-6462 ; 0000-0001-8842-7102 ; 0000-0002-9416-967X ; 0000-0001-5704-3931</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S016164201632259X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28283279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lombardo, Marco, MD, PhD</creatorcontrib><creatorcontrib>Giannini, Daniela, MEng</creatorcontrib><creatorcontrib>Lombardo, Giuseppe, MEng, PhD</creatorcontrib><creatorcontrib>Serrao, Sebastiano, MD, PhD</creatorcontrib><title>Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Purpose To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. Design Prospective randomized controlled clinical trial. Participants Thirty-four eyes of 25 participants with progressive keratoconus were randomized into T-ionto CL (22 eyes) or standard CL (12 eyes). Methods T-ionto CL was performed using an iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by irradiating the cornea with a 10 mW/cm2 ultraviolet A device for 9 minutes. Standard CL was performed according to the Dresden protocol. Main Outcome Measures The primary outcome measure was stabilization of keratoconus after 12 months through analysis of maximum simulated keratometry readings (Kmax , diopters). Other outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resolution [logMAR]), manifest spherical equivalent refraction (D), central corneal thickness (CCT, micrometers) and endothelial cell density (ECD). Follow-up examinations were arranged at 3 and 7 days and 1, 3, 6, and 12 months. Results Twelve months after T-ionto CL and standard CL, Kmax on average flattened by −0.52±1.30 D ( P  = 0.06) and −0.82±1.20 D ( P  = 0.04), respectively. The mean change in CDVA was −0.10±0.12 logMAR ( P  = 0.003) and −0.03±0.06 logMAR ( P  = 0.10) after T-ionto CL and standard CL, respectively. The manifest spherical equivalent refraction changed on average by +0.71±1.44 D ( P  = 0.03) and +0.21±0.76 D ( P  = 0.38), respectively. The CCT and ECD measures did not change significantly in any group at 12 months. Significant differences in the outcome measures between treatments were found in the first week postoperatively. No complications occurred in the T-ionto CL group; 1 eye (8%) had sterile corneal infiltrates, which did not affect the final visual acuity, in the standard CL group. Conclusions Significant visual and refractive improvements were found 12 months after T-ionto CL, though the average improvement in corneal topography readings was slightly lower than the Dresden protocol in the same period.</description><subject>Adult</subject><subject>Cell Count</subject><subject>Collagen - metabolism</subject><subject>Corneal Stroma - metabolism</subject><subject>Corneal Topography</subject><subject>Cross-Linking Reagents</subject><subject>Endothelium, Corneal - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Iontophoresis - methods</subject><subject>Keratoconus - drug therapy</subject><subject>Keratoconus - metabolism</subject><subject>Keratoconus - physiopathology</subject><subject>Male</subject><subject>Ophthalmology</subject><subject>Photochemotherapy - methods</subject><subject>Photosensitizing Agents - therapeutic use</subject><subject>Prospective Studies</subject><subject>Refraction, Ocular - physiology</subject><subject>Riboflavin - therapeutic use</subject><subject>Ultraviolet Rays</subject><subject>Visual Acuity - physiology</subject><subject>Young Adult</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUstu1TAQtRCIXgp_gFCWbBJsx4mTDRK6vCoqgaCV2FmOPen1rWMHOykq38EHY5PCgg0bz-vMjGfOIPSU4Ipg0r44Vn4-LAdZUUx4hUmFGb6HdqRhfck4qe-jXYKRsmUUn6BHMR4xxm1bs4fohHa0qynvd-jnZ-m0n8wP0MXeuyV4a5N6EYy0yTHNMhh3lWzpIsxmOYDdIsFBlsHHWFrjrjPqMub3LJVJX_MBoonF95RTpLTidbI1uOJT8ItX3hbmt36V3NHcQPEBgswBt8bH6MEobYQnd_IUXb59c7F_X55_fHe2f3VeKkb4UvYSuGqGMUmJNR4xxYy3mnSgNSG9ppxIyhs5jKNqRorl0A8dBQmMUUirqU_R863uHPy3FeIiJhMVWCsd-DUK0vGW9RmZoGyDqjxxgFHMwUwy3AqCReZDHMXGh8h8CExE4iOlPbvrsA4T6L9JfwhIgJcbANKcNwaCiMqAU6BNALUI7c3_OvxbQCU6jJL2Gm4hHv0aXNqhICJSgcWXfBP5JEhbU9r0X-tfHPC3aQ</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Lombardo, Marco, MD, PhD</creator><creator>Giannini, Daniela, MEng</creator><creator>Lombardo, Giuseppe, MEng, PhD</creator><creator>Serrao, Sebastiano, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4141-6462</orcidid><orcidid>https://orcid.org/0000-0001-8842-7102</orcidid><orcidid>https://orcid.org/0000-0002-9416-967X</orcidid><orcidid>https://orcid.org/0000-0001-5704-3931</orcidid></search><sort><creationdate>20170601</creationdate><title>Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus</title><author>Lombardo, Marco, MD, PhD ; Giannini, Daniela, MEng ; Lombardo, Giuseppe, MEng, PhD ; Serrao, Sebastiano, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-9ae7c5bf9aea0d0f020476d18edd119d271a275abffc5f20ab9b82eae442e1613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Cell Count</topic><topic>Collagen - metabolism</topic><topic>Corneal Stroma - metabolism</topic><topic>Corneal Topography</topic><topic>Cross-Linking Reagents</topic><topic>Endothelium, Corneal - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Iontophoresis - methods</topic><topic>Keratoconus - drug therapy</topic><topic>Keratoconus - metabolism</topic><topic>Keratoconus - physiopathology</topic><topic>Male</topic><topic>Ophthalmology</topic><topic>Photochemotherapy - methods</topic><topic>Photosensitizing Agents - therapeutic use</topic><topic>Prospective Studies</topic><topic>Refraction, Ocular - physiology</topic><topic>Riboflavin - therapeutic use</topic><topic>Ultraviolet Rays</topic><topic>Visual Acuity - physiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lombardo, Marco, MD, PhD</creatorcontrib><creatorcontrib>Giannini, Daniela, MEng</creatorcontrib><creatorcontrib>Lombardo, Giuseppe, MEng, PhD</creatorcontrib><creatorcontrib>Serrao, Sebastiano, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lombardo, Marco, MD, PhD</au><au>Giannini, Daniela, MEng</au><au>Lombardo, Giuseppe, MEng, PhD</au><au>Serrao, Sebastiano, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>124</volume><issue>6</issue><spage>804</spage><epage>812</epage><pages>804-812</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><abstract>Purpose To compare clinical outcomes of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) and standard corneal cross-linking (standard CL) for the treatment of progressive keratoconus 12 months after the operation. Design Prospective randomized controlled clinical trial. Participants Thirty-four eyes of 25 participants with progressive keratoconus were randomized into T-ionto CL (22 eyes) or standard CL (12 eyes). Methods T-ionto CL was performed using an iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by irradiating the cornea with a 10 mW/cm2 ultraviolet A device for 9 minutes. Standard CL was performed according to the Dresden protocol. Main Outcome Measures The primary outcome measure was stabilization of keratoconus after 12 months through analysis of maximum simulated keratometry readings (Kmax , diopters). Other outcome measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resolution [logMAR]), manifest spherical equivalent refraction (D), central corneal thickness (CCT, micrometers) and endothelial cell density (ECD). Follow-up examinations were arranged at 3 and 7 days and 1, 3, 6, and 12 months. Results Twelve months after T-ionto CL and standard CL, Kmax on average flattened by −0.52±1.30 D ( P  = 0.06) and −0.82±1.20 D ( P  = 0.04), respectively. The mean change in CDVA was −0.10±0.12 logMAR ( P  = 0.003) and −0.03±0.06 logMAR ( P  = 0.10) after T-ionto CL and standard CL, respectively. The manifest spherical equivalent refraction changed on average by +0.71±1.44 D ( P  = 0.03) and +0.21±0.76 D ( P  = 0.38), respectively. The CCT and ECD measures did not change significantly in any group at 12 months. Significant differences in the outcome measures between treatments were found in the first week postoperatively. No complications occurred in the T-ionto CL group; 1 eye (8%) had sterile corneal infiltrates, which did not affect the final visual acuity, in the standard CL group. Conclusions Significant visual and refractive improvements were found 12 months after T-ionto CL, though the average improvement in corneal topography readings was slightly lower than the Dresden protocol in the same period.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28283279</pmid><doi>10.1016/j.ophtha.2017.01.040</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-4141-6462</orcidid><orcidid>https://orcid.org/0000-0001-8842-7102</orcidid><orcidid>https://orcid.org/0000-0002-9416-967X</orcidid><orcidid>https://orcid.org/0000-0001-5704-3931</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0161-6420
ispartof Ophthalmology (Rochester, Minn.), 2017-06, Vol.124 (6), p.804-812
issn 0161-6420
1549-4713
language eng
recordid cdi_proquest_miscellaneous_1876491613
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Cell Count
Collagen - metabolism
Corneal Stroma - metabolism
Corneal Topography
Cross-Linking Reagents
Endothelium, Corneal - pathology
Female
Humans
Iontophoresis - methods
Keratoconus - drug therapy
Keratoconus - metabolism
Keratoconus - physiopathology
Male
Ophthalmology
Photochemotherapy - methods
Photosensitizing Agents - therapeutic use
Prospective Studies
Refraction, Ocular - physiology
Riboflavin - therapeutic use
Ultraviolet Rays
Visual Acuity - physiology
Young Adult
title Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T14%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomized%20Controlled%20Trial%20Comparing%20Transepithelial%20Corneal%20Cross-linking%20Using%20Iontophoresis%20with%20the%20Dresden%20Protocol%20in%20Progressive%20Keratoconus&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Lombardo,%20Marco,%20MD,%20PhD&rft.date=2017-06-01&rft.volume=124&rft.issue=6&rft.spage=804&rft.epage=812&rft.pages=804-812&rft.issn=0161-6420&rft.eissn=1549-4713&rft_id=info:doi/10.1016/j.ophtha.2017.01.040&rft_dat=%3Cproquest_cross%3E1876491613%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1876491613&rft_id=info:pmid/28283279&rft_els_id=S016164201632259X&rfr_iscdi=true